- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
4
High return on equity, past performance and sound balance sheet.
4 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨124.3b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨393.50
7D
-1.0%
1Y
170.8%
Hoechst Pakistan
Market Cap: PK₨30.3b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,198.66
7D
-4.5%
1Y
108.6%
Highnoon Laboratories
Market Cap: PK₨57.0b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,084.54
7D
5.3%
1Y
52.8%
Abbott Laboratories (Pakistan)
Market Cap: PK₨106.5b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,099.58
7D
1.3%
1Y
38.0%